Q1 2019 Syndax Pharmaceuticals Inc Earnings Call Transcript
Good afternoon, ladies and gentlemen, and welcome to the Syndax's First Quarter 2019 Financial Results Conference Call. (Operator Instructions) I would now like to turn the call over to your host, Ms. Melissa Forst with Argot Partners. Please go ahead.
Thank you, operator. Welcome and thank you to those of you joining us today for Syndax's First Quarter 2019 financial results conference call. Joining us this afternoon for prepared remarks will be Dr. Briggs Morrison, Chief Executive Officer; Michael Metzger, President and Chief Operating Officer; and Rick Shea, Chief Financial Officer. And also joining us on today's call for the question-and-answer session will be Dr. Michael Meyers, Chief Medical Officer; and Dr. Peter Ordentlich, Chief Scientific Officer. This call is being accompanied by a slide deck that has been posted on the company's website, so I would ask you to please turn to the forward-looking statements on Slide 2.
Before we begin, I would like to remind you that any statement made during this call
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |